Tag Archives: Israeli investments

Tel Aviv Office Represents U.S. Investor in Investment into Israeli Medical Devices Company Sight Diagnostics Ltd

Tel Aviv Managing Shareholder Joey Shabot and Of-Counsel Ephraim Schmeidler recently represented a US-based family office as part of its investment into Israeli company Sight Diagnostics Ltd (Sight). Sight develops a platform for diagnosing blood diseases using computer vision technology and is a portfolio company of Clal Biotechnology Industries Ltd., traded on the Tel Aviv … Continue Reading

Oct. 2, 2016: Israeli Publication Maariv Sums-Up the Past Year with Israeli Business Leaders

On the eve of the new Jewish year, Maariv, one of Israel’s oldest and most respected publications, asked some leaders of the business community in Israel to share their most significant achievement from the past year. Among the eight people selected by Maariv was Gary M. Epstein, managing shareholder of Greenberg Traurig’s Tel Aviv office; … Continue Reading

Greenberg Traurig Hosts Wharton Israel Conference Monday, June 6, 2016

On June 6, the Boston office of Greenberg Traurig hosted the Wharton Israel Conference “Spotlight on Israeli Innovation in Healthcare and Biopharmaceuticals” for Boston area biotechnology and pharmaceutical professionals with Israeli connections.  Roman Fayerberg (Boston IP) gave the welcome remarks and Chinh H. Pham (Boston IP) moderated a discussion panel “From Idea to Implementation: A … Continue Reading

Lone Star State Meets Michelin Star Chef in Tel Aviv

“…So a world-class chef and a Texan real estate investor walk into an Israeli bar.” Sound like the beginning of corny joke?  Not quite. In February, team members from the recently completed “Texas Retail” deal gathered to celebrate the acquisition by Migdal and Menora, two of Israel’s largest financial institutions, of a significant interest in … Continue Reading

How Israeli entities can plan for US security review and reduce risk when investing in US technology companies

Despite the close US-Israel relationship, Israeli companies and funds seeking to invest in US technologies can face US national security scrutiny that could significantly delay deals, and in some cases prevent or unwind the transaction. Israeli investment in US technology companies, however, should continue to be regarded as an attractive option, as long as the … Continue Reading
LexBlog